A method of providing spatial diversity for critical data delivery in a beamformed mmWave small cell is proposed. The proposed spatial diversity scheme offers duplicate or incremental data/signal transmission and reception by using multiple different beams for the same source and destination. The proposed spatial diversity scheme can be combined with other diversity schemes in time, frequency, and code, etc. for the same purpose. In addition, the proposed spatial diversity scheme combines the physical-layer resources associated with the beams with other resources of the same or different protocol layers. By spatial signaling repetition to avoid Radio Link Failure (RLF) and Handover Failure (HOF), mobility robustness can be enhanced. Mission-critical and/or time-critical data delivery can also be achieved without relying on retransmission.

Methods and compositions are provided for heat treating, e.g. quenching a metal. The quenching composition includes a composition that comprises a polyamidopolyamine compound having a molecular weight of about 500 to about 100,000 and comprising a pendent amino group; and/or a non-polymeric amidoamine having a molecular weight of about 290 to about 5000 and comprising an amino group; and a hydroxyl containing diluent. These compositions impart one or more of the functions of quenching, lubricity, anti/low foaming and/or bioresistance to the quenching fluid.

Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.

The invention relates to polymeric compositions, nanoparticles and vaccines comprising polymeric compositions. The invention extends to medical uses of the polymeric compositions, nanoparticles and vaccines. The invention further extends to methods of producing the polymeric compositions and nanoparticles.

There are provided herein, inter alia, cationic amphipathic polymers, complexes, and compositions comprising same, and methods for their use including for the delivery of therapeutic, diagnostic and imaging agents, including nucleic acids, into a cell. The complexes, compositions and methods may facilitate delivery and targeted release of the therapeutic, diagnostic and imaging agents to particular cell types and tissues.

An alkoxylated polyamidoamine obtainable by a) reacting a polycarboxylic compound having a total number TN of carboxylic groups of 3 to 10 with a primary diamine of formula I H.sub.2NZNH.sub.2 wherein Z represents a bond or an organic group with 1 to 20 carbon atoms in a ratio of 0.3 TN to TN mols of the diamine per 1 mol of the polycarboxylic compound and b) alkoxylating the product obtained in a) with at least 0.5 mol of alkyleneoxide per 1 mol of primary amino groups.

Dendrimer compositions and methods for the treatment of one or more inflammatory and/or angiogenic diseases and/or disorders of the eye include hydroxyl-terminated dendrimers complexed or conjugated with one or more active agents for the treatment or alleviation of one or more symptoms of the diseases of the eye, and/or for diagnosing the diseases and/or disorders of the eye. The dendrimers may include one or more ethylene diamine-core poly(amidoamine) (PAMAM) hydroxyl-terminated generation-4, 5, 6, 7, 8, 9, or 10 dendrimers. The active agents may be VEGFR tyrosine kinase inhibitors including sunitinib or analogues thereof. Preferably, the compositions are suitable for administration via a systemic route to target activated microglia/macrophages in retina/choroid.

Wellbore fluids may include an oleaginous continuous phase; a non-oleaginous discontinuous phase; and a polymeric amidoamine emulsifier stabilizing the non-oleaginous discontinuous phase in the oleaginous continuous phase, wherein the polymeric amidoamine emulsifier has at least 5 repeating units. Wellbore fluids may include an oleaginous continuous phase; a non-oleaginous discontinuous phase; and a polymeric amidoamine emulsifier stabilizing the non-oleaginous discontinuous phase in the oleaginous continuous phase, wherein the polymeric amidoamine emulsifier includes at least 3 repeating units selected from allylamine, polyaminopolyamide, N-alkyl acrylamides, (meth)acrylic acid, alkyleneamine reacted with a dicarboxylic acid, alpha-olefin-alt-maleic anhydride, styrene maleic anhydride, alkylene oxide, wherein one or more amine or acid group on the repeating unit is amidized.

A composition for solid coating formation, includes a mixed solvent including water and a dipolar aprotic solvent, a powdery organic resin which is partially soluble at least in the dipolar aprotic solvent. The powdery organic resin is dissolved or dispersed in the mixed solvent.

Guanidinyl ligand-functionalized polymers, methods of making the same, and substrates bearing a grafted coating of the ligand-functional polymers are described. The grafted polymer has the requisite affinity for binding neutral or negatively charged biomaterials, such as cells, cell debris, bacteria, spores, viruses, nucleic acids, endotoxins and proteins, at pH's near or below the pI's of the biomaterials.